{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:44:20Z","timestamp":1794008660760,"version":"4.8.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673346"],"award-info":[{"award-number":["81673346"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32460190"],"award-info":[{"award-number":["32460190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"\u6d77 \u5357 \u7701 \u79d1 \u5b66 \u6280 \u672f \u5385| Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["ZDKJ202003"],"award-info":[{"award-number":["ZDKJ202003"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor vaccines represent a promising modality in cancer immunotherapy, but the limited immunogenicity of whole-tumor cell vaccines (WTCVs) restricts their clinical translation. Here, we developed a novel bacterialized tumor cell (BTC) vaccine by coating amino-functionalized bacterial lysates onto the surface of tumor cells, a process we define as \u201cbacterialization\u201d. In vitro and in vivo experiments demonstrated that BTCs efficiently promote dendritic cell (DC) phagocytosis, maturation, and antigen cross-presentation, enhance DC migration to draining lymph nodes (DLNs), and remodel the DLN microenvironment by expanding tumor-specific CD8\u207a T cells and memory CD8\u207a T cells, while reducing terminally exhausted CD8\u207a T cells. BTC vaccination elicited robust tumor-specific cellular and humoral immunity, which synergistically suppressed tumor growth and metastasis in five syngeneic murine tumor models with negligible adverse effects. Furthermore, BTC vaccination reversed the immunosuppressive tumor microenvironment by increasing functional CD8\u207a T cell infiltration and reducing inhibitory immune subsets, and exhibited significant synergistic anti-tumor effects when combined with anti-PD-1 immune therapy. These findings demonstrate that BTCs represent a safe and effective novel WTCV candidate with strong clinical translation potential.<\/jats:p>","DOI":"10.1038\/s44321-026-00465-x","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T22:00:20Z","timestamp":1781906420000},"page":"2946-2978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bacterialized tumor cells as vaccine"],"prefix":"10.1038","volume":"18","author":[{"given":"Feng-Ying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6406-0331","authenticated-orcid":false,"given":"Guang-Hong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"465_CR1","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1016\/j.cell.2022.10.006","volume":"185","author":"F Baharom","year":"2022","unstructured":"Baharom F, Ramirez-Valdez RA, Khalilnezhad A, Khalilnezhad S, Dillon M, Hermans D, Fussell S, Tobin KKS, Dutertre CA, Lynn GM et al (2022) Systemic vaccination induces CD8(+) T cells and remodels the tumor microenvironment. Cell 185:4317\u20134332.e4315","journal-title":"Cell"},{"key":"465_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/ni0406-363","volume":"7","author":"MJ Bevan","year":"2006","unstructured":"Bevan MJ (2006) Cross-priming. Nat Immunol 7:363\u2013365","journal-title":"Nat Immunol"},{"key":"465_CR3","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.copbio.2013.05.007","volume":"24","author":"K Blagovic","year":"2013","unstructured":"Blagovic K, Gong ES, Milano DF, Natividad RJ, Asthagiri AR (2013) Engineering cell\u2013cell signaling. Curr Opin Biotechnol 24:940\u2013947","journal-title":"Curr Opin Biotechnol"},{"key":"465_CR4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.cell.2022.01.009","volume":"185","author":"F Borriello","year":"2022","unstructured":"Borriello F, Poli V, Shrock E, Spreafico R, Liu X, Pishesha N, Carpenet C, Chou J, Di Gioia M, McGrath ME et al (2022) An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity. Cell 185:614\u2013629.e621","journal-title":"Cell"},{"key":"465_CR5","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.immuni.2023.07.018","volume":"56","author":"LL Cao","year":"2023","unstructured":"Cao LL, Kagan JC (2023) Targeting innate immune pathways for cancer immunotherapy. Immunity 56:2206\u20132217","journal-title":"Immunity"},{"key":"465_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.it.2004.09.013","volume":"25","author":"FR Carbone","year":"2004","unstructured":"Carbone FR, Belz GT, Heath WR (2004) Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity. Trends Immunol 25:655\u2013658","journal-title":"Trends Immunol"},{"key":"465_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010150","volume":"13","author":"MH Chen","year":"2025","unstructured":"Chen MH, Jiang J, Chen H, Wu RH, Xie W, Dai SZ, Zheng WP, Tan GH, Huang FY (2025) Reinforcing cancer immunotherapy with engineered porous hollow mycobacterium tuberculosis loaded with tumor neoantigens. J Immunother Cancer 13:e010150","journal-title":"J Immunother Cancer"},{"key":"465_CR8","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/j.cell.2024.03.037","volume":"187","author":"H Chi","year":"2024","unstructured":"Chi H, Pepper M, Thomas PG (2024) Principles and therapeutic applications of adaptive immunity. Cell 187:2052\u20132078","journal-title":"Cell"},{"key":"465_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2019.12.005","volume":"64","author":"JD Colbert","year":"2020","unstructured":"Colbert JD, Cruz FM, Rock KL (2020) Cross-presentation of exogenous antigens on MHC I molecules. Curr Opin Immunol 64:1\u20138","journal-title":"Curr Opin Immunol"},{"key":"465_CR10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.it.2018.09.006","volume":"39","author":"G De Lorenzo","year":"2018","unstructured":"De Lorenzo G, Ferrari S, Cervone F, Okun E (2018) Extracellular DAMPs in plants and mammals: immunity, tissue damage and repair. Trends Immunol 39:937\u2013950","journal-title":"Trends Immunol"},{"key":"465_CR11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.tibtech.2011.02.004","volume":"29","author":"SL Demento","year":"2011","unstructured":"Demento SL, Siefert AL, Bandyopadhyay A, Sharp FA, Fahmy TM (2011) Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines. Trends Biotechnol 29:294\u2013306","journal-title":"Trends Biotechnol"},{"key":"465_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300121","volume":"10","author":"L Diao","year":"2023","unstructured":"Diao L, Liu M (2023) Rethinking antigen source: cancer vaccines based on whole tumor cell\/tissue lysate or whole tumor cell. Adv Sci 10:e2300121","journal-title":"Adv Sci"},{"key":"465_CR13","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","volume":"90","author":"G Dranoff","year":"1993","unstructured":"Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539\u20133543","journal-title":"Proc Natl Acad Sci USA"},{"key":"465_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","volume":"8","author":"T Fan","year":"2023","unstructured":"Fan T, Zhang M, Yang J, Zhu Z, Cao W, Dong C (2023) Therapeutic cancer vaccines: advancements, challenges and prospects. Signal Transduct Target Ther 8:450","journal-title":"Signal Transduct Target Ther"},{"key":"465_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S1055-3207(18)30256-4","volume":"7","author":"FS Hodi","year":"1998","unstructured":"Hodi FS, Dranoff G (1998) Genetically modified tumor cell vaccines. Surg Oncol Clin North Am 7:471\u2013485","journal-title":"Surg Oncol Clin North Am"},{"key":"465_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121141","volume":"278","author":"FY Huang","year":"2021","unstructured":"Huang FY, Dai SZ, Wang JY, Lin YY, Wang CC, Zheng WP, Tan GH (2021) Engineered porous\/hollow Burkholderia pseudomallei loading tumor lysate as a vaccine. Biomaterials 278:121141","journal-title":"Biomaterials"},{"key":"465_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106613","volume":"187","author":"FY Huang","year":"2023","unstructured":"Huang FY, Dai SZ, Xu WT, Xiong W, Sun Y, Huang YH, Wang JY, Lin YY, Chen H, Tan GH et al (2023) 3\u2019-epi-12beta-hydroxyfroside-mediated autophagy degradation of RIPK1\/RIPK3 necrosomes leads to anergy of immunogenic cell death in triple-negative breast cancer cells. Pharmacol Res 187:106613","journal-title":"Pharmacol Res"},{"key":"465_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000330","volume":"8","author":"FY Huang","year":"2020","unstructured":"Huang FY, Wang JY, Dai SZ, Lin YY, Sun Y, Zhang L, Lu Z, Cao R, Tan GH (2020) A recombinant oncolytic Newcastle virus expressing MIP-3alpha promotes systemic antitumor immunity. J Immunother Cancer 8:e000330","journal-title":"J Immunother Cancer"},{"key":"465_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nri3254","volume":"12","author":"OP Joffre","year":"2012","unstructured":"Joffre OP, Segura E, Savina A, Amigorena S (2012) Cross-presentation by dendritic cells. Nat Rev Immunol 12:557\u2013569","journal-title":"Nat Rev Immunol"},{"key":"465_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.891878","volume":"12","author":"H Kim","year":"2022","unstructured":"Kim H, Shin SJ (2022) Pathological and protective roles of dendritic cells in Mycobacterium tuberculosis infection: Interaction between host immune responses and pathogen evasion. Front Cell Infect Microbiol 12:891878","journal-title":"Front Cell Infect Microbiol"},{"key":"465_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.tim.2018.02.012","volume":"26","author":"A Koch","year":"2018","unstructured":"Koch A, Mizrahi V (2018) Mycobacterium tuberculosis. Trends Microbiol 26:555\u2013556","journal-title":"Trends Microbiol"},{"key":"465_CR22","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.immuni.2019.04.006","volume":"50","author":"J Komuczki","year":"2019","unstructured":"Komuczki J, Tuzlak S, Friebel E, Hartwig T, Spath S, Rosenstiel P, Waisman A, Opitz L, Oukka M, Schreiner B et al (2019) Fate-mapping of GM-CSF expression identifies a discrete subset of inflammation-driving T helper cells regulated by cytokines IL-23 and IL-1\u03b2. Immunity 50:1289\u20131304.e1286","journal-title":"Immunity"},{"key":"465_CR23","doi-asserted-by":"publisher","first-page":"8291","DOI":"10.1016\/j.biomaterials.2013.07.020","volume":"34","author":"SY Liu","year":"2013","unstructured":"Liu SY, Wei W, Yue H, Ni DZ, Yue ZG, Wang S, Fu Q, Wang YQ, Ma GH, Su ZG (2013) Nanoparticles-based multi-adjuvant whole cell tumor vaccine for cancer immunotherapy. Biomaterials 34:8291\u20138300","journal-title":"Biomaterials"},{"key":"465_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41568-024-00785-5","volume":"25","author":"C Luri-Rey","year":"2025","unstructured":"Luri-Rey C, Teijeira \u00c1, Wculek SK, de Andrea C, Herrero C, Lopez-Janeiro A, Rodr\u00edguez-Ruiz ME, Heras I, Aggelakopoulou M, Berraondo P et al (2025) Cross-priming in cancer immunology and immunotherapy. Nat Rev Cancer 25:249\u2013273","journal-title":"Nat Rev Cancer"},{"key":"465_CR25","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1182\/blood-2009-11-255935","volume":"115","author":"D Matheoud","year":"2010","unstructured":"Matheoud D, Peri\u00e9 L, Hoeffel G, Vimeux L, Parent I, Mara\u00f1\u00f3n C, Bourdoncle P, Renia L, Prevost-Blondel A, Lucas B et al (2010) Cross-presentation by dendritic cells from live cells induces protective immune responses in vivo. Blood 115:4412\u20134420","journal-title":"Blood"},{"key":"465_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/jleuko\/qiad120","volume":"115","author":"MA McBride","year":"2024","unstructured":"McBride MA, Stothers CL, Fensterheim BA, Caja KR, Owen AM, Hernandez A, Bohannon JK, Patil NK, Ali S, Dalal S et al (2024) Bacteria- and fungus-derived PAMPs induce innate immune memory via similar functional, metabolic, and transcriptional adaptations. J Leukoc Biol 115:358\u2013373","journal-title":"J Leukoc Biol"},{"key":"465_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40207-y","volume":"14","author":"J Meng","year":"2023","unstructured":"Meng J, Lv Y, Bao W, Meng Z, Wang S, Wu Y, Li S, Jiao Z, Tian Z, Ma G et al (2023) Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation. Nat Commun 14:4505","journal-title":"Nat Commun"},{"key":"465_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2021.101149","volume":"24","author":"X Meng","year":"2021","unstructured":"Meng X, Lei Y, Zhang X, Sun K, Zhang L, Wang Z (2021) Cancer immunotherapy: classification, therapeutic mechanisms, and nanomaterial-based synergistic therapy. Appl Mater Today 24:101149","journal-title":"Appl Mater Today"},{"key":"465_CR29","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","volume":"11","author":"J Neefjes","year":"2011","unstructured":"Neefjes J, Jongsma ML, Paul P, Bakke O (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11:823\u2013836","journal-title":"Nat Rev Immunol"},{"key":"465_CR30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41416-023-02327-6","volume":"129","author":"A P\u00e9rez-Ba\u00f1os","year":"2023","unstructured":"P\u00e9rez-Ba\u00f1os A, Gleisner MA, Flores I, Pereda C, Navarrete M, Araya JP, Navarro G, Quezada-Monr\u00e1s C, Tittarelli A, Salazar-Onfray F (2023) Whole tumour cell-based vaccines: tuning the instruments to orchestrate an optimal antitumour immune response. Br J Cancer 129:572\u2013585","journal-title":"Br J Cancer"},{"key":"465_CR31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.exphem.2016.06.003","volume":"44","author":"KA Read","year":"2016","unstructured":"Read KA, Powell MD, McDonald PW, Oestreich KJ (2016) IL-2, IL-7, and IL-15: multistage regulators of CD4+ T helper cell differentiation. Exp Hematol 44:799\u2013808","journal-title":"Exp Hematol"},{"key":"465_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2019.07.002","volume":"309","author":"MM Romero","year":"2019","unstructured":"Romero MM, Duarte A, Pastorini M, Aleman M (2019) Role of alpha-glucan-induced oxygen species in dendritic cells and its impact in immune response against tuberculosis. Int J Med Microbiol 309:151328","journal-title":"Int J Med Microbiol"},{"key":"465_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1128\/CMR.16.3.463-496.2003","volume":"16","author":"I Smith","year":"2003","unstructured":"Smith I (2003) Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 16:463\u2013496","journal-title":"Clin Microbiol Rev"},{"key":"465_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/pro.3346","volume":"27","author":"F Squeglia","year":"2018","unstructured":"Squeglia F, Ruggiero A, De Simone A, Berisio R (2018) A structural overview of mycobacterial adhesins: key biomarkers for diagnostics and therapeutics. Protein Sci 27:369\u2013380","journal-title":"Protein Sci"},{"key":"465_CR35","doi-asserted-by":"publisher","first-page":"8795","DOI":"10.1158\/0008-5472.CAN-04-1776","volume":"64","author":"J Stagg","year":"2004","unstructured":"Stagg J, Wu JH, Bouganim N, Galipeau J (2004) Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy. Cancer Res 64:8795\u20138799","journal-title":"Cancer Res"},{"key":"465_CR36","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1046\/j.1365-2567.2000.00963.x","volume":"99","author":"RE Tascon","year":"2000","unstructured":"Tascon RE, Soares CS, Ragno S, Stavropoulos E, Hirst EM, Colston MJ (2000) Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice. Immunology 99:473\u2013480","journal-title":"Immunology"},{"key":"465_CR37","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1039\/D5BM00914F","volume":"13","author":"X Wang","year":"2025","unstructured":"Wang X, Xu H, Wang H, Hua R, Wu S, Xu J, Cheng X, Shi H (2025) Construction strategies of whole tumor cell vaccines. Biomater Sci 13:4885\u20134897","journal-title":"Biomater Sci"},{"key":"465_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02305-x","volume":"24","author":"M Zhang","year":"2025","unstructured":"Zhang M, Liu C, Tu J, Tang M, Ashrafizadeh M, Nabavi N, Sethi G, Zhao P, Liu S (2025) Advances in cancer immunotherapy: historical perspectives, current developments, and future directions. Mol Cancer 24:136","journal-title":"Mol Cancer"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00465-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00465-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00465-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:31:22Z","timestamp":1783924282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00465-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,13]]}},"alternative-id":["465"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00465-x","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The method for preparing \u201cBacterialized tumor cells (BTCs)\u201d in this study has been patented and granted authorization in the United States (US11357843B2) and China (ZL201910322888.3).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}